pubmed-article:18052089 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0001128 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0040399 | lld:lifeskim |
pubmed-article:18052089 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
pubmed-article:18052089 | pubmed:issue | 26 | lld:pubmed |
pubmed-article:18052089 | pubmed:dateCreated | 2007-12-20 | lld:pubmed |
pubmed-article:18052089 | pubmed:abstractText | Both enantiomers of 2-amino-2-methyl-4-iodo-3-(E)-butenoic acid (IVAIB, 5) were radioiodoinated in 65-72% yield. (S)-IVAIB entered 9L gliosarcoma cells primarily via A-type transport in vitro with higher uptake than (R)-IVAIB. Biodistribution studies in rats with 9L gliosarcoma brain tumors demonstrated higher tumor to brain ratios with (S)-IVAIB (75:1 at 1 h) than (R)-IVAIB (7.7:1). In this model, (S)-IVAIB is superior to (R)-IVAIB and is a promising radiotracer for brain tumor imaging. | lld:pubmed |
pubmed-article:18052089 | pubmed:language | eng | lld:pubmed |
pubmed-article:18052089 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18052089 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18052089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18052089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18052089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18052089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18052089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18052089 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18052089 | pubmed:month | Dec | lld:pubmed |
pubmed-article:18052089 | pubmed:issn | 0022-2623 | lld:pubmed |
pubmed-article:18052089 | pubmed:author | pubmed-author:OlsonJeffreyJ | lld:pubmed |
pubmed-article:18052089 | pubmed:author | pubmed-author:YuWeipingW | lld:pubmed |
pubmed-article:18052089 | pubmed:author | pubmed-author:GoodmanMark... | lld:pubmed |
pubmed-article:18052089 | pubmed:author | pubmed-author:McConathyJona... | lld:pubmed |
pubmed-article:18052089 | pubmed:author | pubmed-author:CampVernon... | lld:pubmed |
pubmed-article:18052089 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18052089 | pubmed:day | 27 | lld:pubmed |
pubmed-article:18052089 | pubmed:volume | 50 | lld:pubmed |
pubmed-article:18052089 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18052089 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18052089 | pubmed:pagination | 6718-21 | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:meshHeading | pubmed-meshheading:18052089... | lld:pubmed |
pubmed-article:18052089 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:18052089 | pubmed:articleTitle | Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography. | lld:pubmed |
pubmed-article:18052089 | pubmed:affiliation | mgoodma@emory.edu. | lld:pubmed |
pubmed-article:18052089 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18052089 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:18052089 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:18052089 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18052089 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18052089 | lld:pubmed |